EGT0001474
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for EGT0001474, covering 2011-08-12 to 2011-08-17. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacokinetics Study of EGT0001474 in Subjects With Type 2 Diabetes [Phase 1]